| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 01/13/2000 | WO2000001827A2 Polyketides, their preparation, and materials for use therein |
| 01/13/2000 | WO2000001826A2 Stabilized variants of streptomyces subtilisin inhibitor |
| 01/13/2000 | WO2000001825A1 HELICOBACTER ANTIGEN (η-GLUTAMYLTRANSPEPTIDASE) AND SEQUENCES ENCODING THE SAME |
| 01/13/2000 | WO2000001824A2 Method for genetic engineering of disease resistance using the drr206 class of proteins |
| 01/13/2000 | WO2000001823A2 Flt3-l mutants and methods of use |
| 01/13/2000 | WO2000001822A1 Specific binding proteins including antibodies which bind to the necrotic centre of tumours, and uses thereof |
| 01/13/2000 | WO2000001821A2 Neurotransmission associated proteins |
| 01/13/2000 | WO2000001820A2 Nucleic acid molecules encoding nuclear hormone receptor coactivators, and uses thereof |
| 01/13/2000 | WO2000001819A1 Human elk, a voltage-gated potassium channel subunit |
| 01/13/2000 | WO2000001818A1 Human emr1-like g protein coupled receptor |
| 01/13/2000 | WO2000001817A2 Mammalian genes; dendritic cell prostaglandin-like transponder (dc-pgt), hdtea84, hsljd37r and rankl, hcc5 chemokine, deubiquitinating 11 and 12 (dub11, dub12), md-1, md2 and cyclin e2, related reagents and methods |
| 01/13/2000 | WO2000001816A1 TUMOUR SUPPRESSOR GENE DBCCR1 AT 9q32-33 |
| 01/13/2000 | WO2000001815A2 Neurotrophic factors |
| 01/13/2000 | WO2000001814A2 Non-human mammal wherein a gene coding for an scuz-protein can be de-activated in a time-specific or tissue-specific manner |
| 01/13/2000 | WO2000001813A2 Peptide inhibitors of androgen-independent activation of androgen receptor |
| 01/13/2000 | WO2000001812A1 Fungal signal peptide sequences for chitinolytic enzymes and uses thereof |
| 01/13/2000 | WO2000001811A1 Kv6.2, A VOLTAGE-GATED POTASSIUM CHANNEL SUBUNIT |
| 01/13/2000 | WO2000001810A1 Novel promoter sequences of myostatin gene |
| 01/13/2000 | WO2000001809A1 TAXOL PRODUCTION VIA GENERATION OF EXTRACHROMOSOMAL DNAs IN THE FUNGUS $i(PESTALOTIOPSIS) |
| 01/13/2000 | WO2000001808A2 IN VIVO ADDITION OF TELOMERIC REPEATS TO EXOGENOUS DNA GENERATES EXTRACHROMOSOMAL DNAs IN THE FUNGUS $i(PESTALOTIOPSIS) |
| 01/13/2000 | WO2000001806A1 Use of the first polar body chromosomes for the production of embryos |
| 01/13/2000 | WO2000001805A1 Cells and animals deficient in protein kinase c epsilon |
| 01/13/2000 | WO2000001804A2 Nucleotide sequence encoding a protein with beta glucanase activity and use thereof |
| 01/13/2000 | WO2000001801A1 Ftsz multimeric proteins and their uses |
| 01/13/2000 | WO2000001796A2 Starch debranching enzymes |
| 01/13/2000 | WO2000001728A1 Galectin 11 |
| 01/13/2000 | WO2000001725A1 Saccharide transporter |
| 01/13/2000 | WO2000001724A1 Microsporidium polar tube proteins, nucleic acids coding for said proteins and their uses |
| 01/13/2000 | WO2000001722A1 Manipulation of mlo genes to enhance disease resistance in plants |
| 01/13/2000 | WO2000001721A1 Methods and compositions to enhance disease resistance in plants by expression of mlo3 from maize |
| 01/13/2000 | WO2000001713A2 Diacylglycerol acyl transferase proteins |
| 01/13/2000 | WO2000001712A2 Chemically modified proteins with a carbohydrate moiety |
| 01/13/2000 | WO2000001650A1 Method of vitamin production |
| 01/13/2000 | WO2000001440A2 Methods for treating neurological injuries and disorders |
| 01/13/2000 | WO2000001405A1 Cartilage cell differentiation promoters |
| 01/13/2000 | WO2000001393A2 OLIGONUCLEOTIDE INHIBITORS OF bcl-xL |
| 01/13/2000 | WO2000001223A1 LECTINS TO CONFER RESISTANCE TO INSECTS IN $i(BRASSICA) |
| 01/13/2000 | WO2000001222A2 Development of novel, highly chemoprotectant crucifer germplasm |
| 01/13/2000 | WO2000001221A2 Methods for interspecific hybridization |
| 01/13/2000 | WO1999060148A3 Display of viral proteins as ligands for cell-surface receptor |
| 01/13/2000 | WO1999060135A8 Generation of multiple gene products from chimeric fusion proteins by cleavage with ubiquitous endoproteases |
| 01/13/2000 | WO1999060125A3 Secreted proteins |
| 01/13/2000 | WO1999058688A3 Nucleic acid molecules which code for enzymes derived from wheat and which are involved in the synthesis of starch |
| 01/13/2000 | WO1999058118A3 METHODS FOR REGULATING HEMATOPOIESIS USING CpG-OLIGONUCLEOTIDES |
| 01/13/2000 | WO1999057241A3 Myelin basic protein peptides and uses thereof |
| 01/13/2000 | WO1999053953A3 Methods and products related to metabolic interactions in disease |
| 01/13/2000 | WO1999053060A3 Glaucoma therapeutics and diagnostics based on a novel human transcription factor |
| 01/13/2000 | WO1999053047A3 Porcine adenovirus type 3 genome |
| 01/13/2000 | WO1999051731A3 Maize histone deacetylases and their use |
| 01/13/2000 | WO1999051636A9 Gaba b receptor |
| 01/13/2000 | WO1999046286A3 Assays and reagents for identifying anti-fungal agents, and uses related thereto |
| 01/13/2000 | WO1999041007B1 Method and apparatus for chemical and biochemical reactions using photo-generated reagents |
| 01/13/2000 | WO1999037774A3 Differentiation-associated sequences and methods of use therefor |
| 01/13/2000 | WO1999018909A3 Interferon-gamma regulatory factors |
| 01/13/2000 | DE19830874A1 Verfahren zur Stabilisierung und Verbesserung des Gentransfers von genetischem Material in Säugerzellen A process for the stabilization and improvement of the gene transfer of genetic material into mammalian cells |
| 01/13/2000 | DE19830141A1 Rekombinante Herpesviren für die Erzeugung rekombinanter Adeno-Assoziierter-Viren Recombinant herpes viruses for the production of recombinant adeno-associated virus |
| 01/13/2000 | DE19822985C1 Tumorsuppressorgene der p53-Familie Tumor suppressor p53 family |
| 01/13/2000 | CA2831321A1 Production of isoprenoid in recombinant yeast |
| 01/13/2000 | CA2789083A1 Characterisation of gene function using double stranded rna inhibition |
| 01/13/2000 | CA2402839A1 Galectin 11 |
| 01/13/2000 | CA2341640A1 Methods for making polyketides using altered pks |
| 01/13/2000 | CA2337095A1 Method for genetic engineering of disease resistance using the drr206 class of proteins |
| 01/13/2000 | CA2336893A1 Means and methods for enhancing the content of sulfur compounds in plants |
| 01/13/2000 | CA2336718A1 Methods for treating neurological injuries and disorders |
| 01/13/2000 | CA2336417A1 Development of novel, highly chemoprotectant crucifer germplasm |
| 01/13/2000 | CA2336406A1 Galectin 11 |
| 01/13/2000 | CA2336384A1 Oligonucleotide inhibitors of bcl-xl |
| 01/13/2000 | CA2336132A1 In vivo addition of telomeric repeats to exogenous dna generates extrachromosomal dnas in the fungus pestalotiopsis |
| 01/13/2000 | CA2336122A1 Taxol production via generation of extrachromosomal dnas in the fungus pestalotiopsis |
| 01/13/2000 | CA2333919A1 Microsporidium polar tube proteins, nucleic acids coding for said proteins and their uses |
| 01/13/2000 | CA2332699A1 Antisense oligonucleotides targeted to il-15 |
| 01/13/2000 | CA2332698A1 Sugar transporter |
| 01/13/2000 | CA2332697A1 Starch debranching enzymes |
| 01/13/2000 | CA2332638A1 Visualization of enzyme-catalysed reactions using ph indicators: rapid screening of hydrolase libraries for enantioselective enzymes |
| 01/13/2000 | CA2332573A1 Mammalian genes; dendritic cell prostaglandin-like transponder (dc-pgt), hdtea84, hsljd37r and rankl, hcc5 chemokine, deubiquitinating 11 and 12 (dub11, dub12), md-1, md2 and cyclin e2, related reagents and methods |
| 01/13/2000 | CA2332564A1 Stabilized variants of streptomyces subtilisin inhibitor |
| 01/13/2000 | CA2332555A1 Novel promoter sequences of myostatin gene |
| 01/13/2000 | CA2332491A1 Polyketides, their preparation, and materials for use therein |
| 01/13/2000 | CA2332345A1 Flt3-l mutants and methods of use |
| 01/13/2000 | CA2332309A1 Neurotransmission associated proteins |
| 01/13/2000 | CA2332177A1 Proteases fused with variants of streptomyces subtilisin inhibitor |
| 01/13/2000 | CA2331829A1 Kv6.2, a voltage-gated potassium channel subunit |
| 01/13/2000 | CA2331774A1 Inducible promoters |
| 01/13/2000 | CA2331765A1 Formaldehyde dehydrogenase genes from methylotrophic yeasts |
| 01/13/2000 | CA2331394A1 Human emr1-like g protein coupled receptor |
| 01/13/2000 | CA2331343A1 Production of isoprenoid in recombinant yeast |
| 01/13/2000 | CA2302169A1 Inhibitors of androgen-independent activation of androgen receptor |
| 01/12/2000 | EP0971039A2 Processes useful for nucleic acid amplification and sequencing, and for the production of nucleic acid having decreased thermodynamic stability |
| 01/12/2000 | EP0971034A1 Process for preparing antibody molecules |
| 01/12/2000 | EP0971033A2 Test and model for Alzheimer's disease |
| 01/12/2000 | EP0970966A1 Fungal antigens and process for producing the same |
| 01/12/2000 | EP0970377A1 Diagnosis of epithelial cell abnormalities |
| 01/12/2000 | EP0970372A1 Assay for disease related conformation of a protein |
| 01/12/2000 | EP0970249A2 Method for detecting mutated allels |
| 01/12/2000 | EP0970247A1 Detection of dna damaging agents |
| 01/12/2000 | EP0970243A1 Diagnosis and treatment of glaucoma |
| 01/12/2000 | EP0970242A1 Method for analyzing quantitative expression of genes |
| 01/12/2000 | EP0970241A1 (in vitro) evolution of oligonucleotides |
| 01/12/2000 | EP0970240A1 Artificial mismatch hybridization |
| 01/12/2000 | EP0970237A1 Dna construct to confer multiple traits on plants |